Light Mode
$0.0010 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0010, and at the day’s high of $0.0010
-0.19 (-99.47%) / 6M
Momentum, market sentiment, and recent alerts
ZVSA reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -99.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Lighthouse Point, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.